Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 129 | 2 | 143 | +16 |
| Shares | 75.8M | 5.45M | 79.2M | +8.87M (+12.6%) |
| Value | $611.7M | $44.0M | $442.0M | −$125.7M (−22.1%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (33)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (17)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Avidity Partners Management LP | 1,265,200 | $10.2M |
| Adage Capital Partners GP, L.L.C. | 500,000 | $4.04M |
| Altium Capital Management LP | 355,000 | $2.86M |
| Diadema Partners LP | 214,291 | $1.73M |
| Monaco Asset Management SAM | 135,561 | $1.09M |
| Hudson Bay Capital Management LP | 120,000 | $968.4K |
| M&T Bank Corp | 99,234 | $801.1K |
| Natixis | 79,900 | $644.8K |
| Verition Fund Management LLC | 34,205 | $276.0K |
| ExodusPoint Capital Management, LP | 23,417 | $189.0K |
| Engineers Gate Manager LP | 16,554 | $133.6K |
| Persistent Asset Partners Ltd | 7,373 | $76.8K |
| Virtus ETF Advisers LLC | 8,434 | $68.1K |
| R Squared Ltd | 1,800 | $14.5K |
| Versant Capital Management, Inc | 478 | $3.86K |
| Skopos Labs, Inc. | 105 | $848 |
| SRS Capital Advisors, Inc. | 68 | $549 |
Not filed for Q1 2025 yet (2)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nextech Invest AG | 5,285,714 | $42.7M |
| Nuveen Asset Management, LLC | 167,502 | $1.35M |